RxDoctor Payments DataLook up a doctor →

Ron Waksman, MD

Interventional Cardiology · Washington, DCNPI 1134170459

Payments from drug & device makers

$24,144,883in general payments, 2019–2025

Across 1,062 payments — averaging $22,735 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Philips North America LLC$11.1M
  • Medtronic$7.9M
  • M.a. Med Alliance S.A.$1.9M
  • Biotronik Inc.$1M
  • Boston Scientific$570K
  • Abbott$552K
  • plus $1M from 32 others
$35,250in research payments, 2019–2025

Across 3 payments — averaging $11,750 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Philips North America LLC$34K
  • Medtronic$1K

What the payments were for

  • Consulting fees$826,17090%
  • Speaking & faculty fees$36,2004%
  • Travel & lodging$42,7975%
  • Food & beverage$9,4681%
  • Entertainment$590%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few interventional cardiology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$19,520
Medicare patients
32
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →